Nanomedicine is advancing GI drug delivery through targeted therapies and personalized treatments, offering more precise and effective care for gastrointestinal disorders.
Integrative nutritional therapies, including the low FODMAP diet, probiotics, and prebiotics, are increasingly used to manage IBS.
Breath tests are becoming a cornerstone in the diagnosis and management of gastrointestinal (GI)...
Read More
MicroRNA biomarkers are proving useful in identifying cancers such as colorectal, gastric, and esophageal cancers at their nascent stages.
Read More
The integration of AI in digital pathology is transforming the landscape of diagnostics in gastrointestinal diseases.
Read More
Next-generation sequencing (NGS) is transforming how clinicians understand, diagnose, and treat a range of gastrointestinal diseases.
Read More
The emergence of liquid biopsy technology marks a significant advancement in the early detection and management of gastrointestinal cancers.
Read More
The use of biomarkers has revolutionized the approach to treating gastrointestinal disorders, enhancing the effectiveness of pharmacotherapy.
Read More